Compare LOOP & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOOP | ETON |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.7M | 1.3B |
| IPO Year | 2010 | 2018 |
| Metric | LOOP | ETON |
|---|---|---|
| Price | $0.54 | $56.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | ★ 1.5M | 428.6K |
| Earning Date | 05-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | $10,889,000.00 | ★ $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $174.82 | $47.23 |
| P/E Ratio | ★ N/A | $136.12 |
| Revenue Growth | ★ 7016.99 | 104.94 |
| 52 Week Low | $0.41 | $14.27 |
| 52 Week High | $1.99 | $66.37 |
| Indicator | LOOP | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 49.17 |
| Support Level | N/A | $15.75 |
| Resistance Level | $0.97 | $66.37 |
| Average True Range (ATR) | 0.04 | 2.54 |
| MACD | 0.00 | -1.32 |
| Stochastic Oscillator | 31.79 | 18.40 |
Loop Industries Inc is a technology company whose mission is to accelerate the world's shift toward sustainable PET plastic and polyester fiber and away from dependence on fossil fuels. Loop Industries owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles, packaging, and textiles such as carpets and clothing, into its base building block monomers, DMT and MEG.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.